These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 12138206)

  • 1. Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5.
    Zhang ZK; Davies KP; Allen J; Zhu L; Pestell RG; Zagzag D; Kalpana GV
    Mol Cell Biol; 2002 Aug; 22(16):5975-88. PubMed ID: 12138206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
    Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
    Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle.
    Versteege I; Medjkane S; Rouillard D; Delattre O
    Oncogene; 2002 Sep; 21(42):6403-12. PubMed ID: 12226744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
    Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J
    J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss.
    Tsikitis M; Zhang Z; Edelman W; Zagzag D; Kalpana GV
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12129-34. PubMed ID: 16099835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors.
    Alarcon-Vargas D; Zhang Z; Agarwal B; Challagulla K; Mani S; Kalpana GV
    Oncogene; 2006 Feb; 25(5):722-34. PubMed ID: 16302003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells.
    Oruetxebarria I; Venturini F; Kekarainen T; Houweling A; Zuijderduijn LM; Mohd-Sarip A; Vries RG; Hoeben RC; Verrijzer CP
    J Biol Chem; 2004 Jan; 279(5):3807-16. PubMed ID: 14604992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization.
    Medjkane S; Novikov E; Versteege I; Delattre O
    Cancer Res; 2004 May; 64(10):3406-13. PubMed ID: 15150092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism.
    Kuwahara Y; Charboneau A; Knudsen ES; Weissman BE
    Cancer Res; 2010 Mar; 70(5):1854-65. PubMed ID: 20179200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB.
    Betz BL; Strobeck MW; Reisman DN; Knudsen ES; Weissman BE
    Oncogene; 2002 Aug; 21(34):5193-203. PubMed ID: 12149641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INI1/hSNF5/BAF47 represses c-fos transcription via a histone deacetylase-dependent manner.
    Pan X; Zhai L; Sun R; Li X; Zeng X
    Biochem Biophys Res Commun; 2005 Dec; 337(4):1052-8. PubMed ID: 16219292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters.
    Kuwahara Y; Wei D; Durand J; Weissman BE
    Mol Cancer Res; 2013 Mar; 11(3):251-60. PubMed ID: 23364536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors.
    Uno K; Takita J; Yokomori K; Tanaka Y; Ohta S; Shimada H; Gilles FH; Sugita K; Abe S; Sako M; Hashizume K; Hayashi Y
    Genes Chromosomes Cancer; 2002 May; 34(1):33-41. PubMed ID: 11921280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrase interactor 1 in health and disease.
    Das S
    Curr Protein Pept Sci; 2015; 16(6):478-90. PubMed ID: 25772157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knock down of hSNF5/Ini1 causes cell cycle arrest and apoptosis in a p53-dependent manner.
    Kato H; Honma R; Sanda T; Fujiwara T; Ito E; Yanagisawa Y; Imai J; Okamoto T; Watanabe S
    Biochem Biophys Res Commun; 2007 Sep; 361(3):580-5. PubMed ID: 17669367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.
    Rampalli S; Pavithra L; Bhatt A; Kundu TK; Chattopadhyay S
    Mol Cell Biol; 2005 Oct; 25(19):8415-29. PubMed ID: 16166625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesis.
    Craig E; Zhang ZK; Davies KP; Kalpana GV
    EMBO J; 2002 Jan; 21(1-2):31-42. PubMed ID: 11782423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1.
    Caramel J; Quignon F; Delattre O
    Cancer Res; 2008 Aug; 68(15):6154-61. PubMed ID: 18676838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatin-remodeling factor INI1/hSNF5/BAF47 is involved in activation of the colony stimulating factor 1 promoter.
    Pan X; Song Z; Zhai L; Li X; Zeng X
    Mol Cells; 2005 Oct; 20(2):183-8. PubMed ID: 16267391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human SNF5/INI1 protein facilitates the function of the growth arrest and DNA damage-inducible protein (GADD34) and modulates GADD34-bound protein phosphatase-1 activity.
    Wu DY; Tkachuck DC; Roberson RS; Schubach WH
    J Biol Chem; 2002 Aug; 277(31):27706-15. PubMed ID: 12016208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.